ABSTRACT. Stem cell transplantation is one of the most promising yet enigmatic treatments for spinal cord injury (SCI), a common problem in dogs. As pre-differentiated mesenchymal stem cells (MSCs) can be expanded and differentiated into neurospheres in vitro, before being transplanted back, they may prove to be more beneficial for treating SCI. Therefore, we compared the endogenous differentiation potential, including the neuronal cell differentiation, of neurospheres from canine bone marrow MSCs (cBMMSCs) with that of the adipose tissuederived MSCs (cADMSCs). Nestin-positive neurospheres were generated from MSCs derived from the bone marrow and adipose tissue. Neuronal cells were differentiated from the neurospheres derived from both these tissues. Gene expression analysis revealed that Nestin, βIII-tubulin, NCAM, OCT4 and SOX2 were expressed in MSCs and the corresponding neurospheres. Notably, cBMMSC-derived neuronal cells expressed higher levels of βIII-tubulin. The mRNA expressions of NANOG, Nestin, OCT4 and SOX2 were upregulated in neurospheres derived from both. Immunofluorescence analysis detected the expression of neuronal markers, namely, βIII-tubulin, GFAP, S100, NF200 and MAP2, in differentiated neuron-like cells. Our findings highlight that both cBMMSCs and cADMSCs could be differentiated into neurospheres and neuron-like cells, and therefore, these cells are suitable candidates for cell transplantation. Further, cADMSCs form a more suitable cell source, as larger number of cells could be harvested from cADMSC-derived neurospheres. Future studies employing in vivo transplantation models to investigate the effectiveness of MSCs for treating SCI are warranted. KEY WORDS: adipose-derived mesenchymal stem cell, bone marrow-derived mesenchymal stem cell, canine, neurosphere, spinal cord injury.
Spinal cord injury (SCI), a devastating disease in dogs, is commonly caused by motor vehicle accidents or intervertebral disease (IVDD). Due to poor prognosis of severe SCI cases, the patients suffer from sustained incontinence and do not regain the ability to walk. Since there is no definitive treatment for severe SCI, various strategies, including medical and surgical therapies or rehabilitation, have been applied and evaluated. Among them, stem cell transplantation therapy is the most promising treatment for severe SCI.
Several cell types, including embryonic stem (ES) cells [17] , olfactory ensheathing cells, Schwann cells [27] , mesenchymal stem cells (MSCs) [37] , neural stem cells (NSCs) [21] and induced pluripotent stem (iPS) cells [18] , have been studied for the treatment of severe SCI. Among these, ES cells and iPS cells being pluripotent hold tremendous promise in regenerative medicine. However, there are several obstacles to their implementation, including tumorigenic, immunological and ethical problems. On the other hand, MSCs derived from the bone marrow, adipose tissue, peripheral blood or umbilical cord blood are multipotent cells, which could be easily isolated from adult issues with minimal cost and possess low immunogenicity; moreover, the use of these MSCs is not ethically restricted. Therefore, MSCs provide an attractive and practical source of stem cells for cell transplantation therapy in veterinary patients.
Various mechanisms, such as neuroprotection, secretion of growth factors and cytokines or remyelination, have been proposed as therapeutic effects of stem cell transplantation for SCI. During recent years, the replacement of damaged neurons by cell transplantation has been enthusiastically explored as a potential treatment option [24] . For this purpose, NSCs, undifferentiated MSCs and mature neuronal cells directly differentiated from MSCs have been studied in many SCI models. From the viewpoint of cell replacement in SCI therapy, NSCs may be most effective among these cell sources. NSCs can grow and expand as neurospheres, which represent a heterogeneous mixture of cellular aggregates [26] and have been reported to differentiate into neurons following transplantation into mice with SCI [5, 21] . In addition, neurospheres generated from human MSCs exhibit electrophysiological properties after subsequently differentiation into neuronal cells in vitro and retain the capability to differentiate into neuronal and glial cells after transplantation into mouse brain [16] . On the contrary, the normal electrophysiological properties were absent when neuronal cells were differentiated directly from MSCs [35] and Hermann et al. indicated the importance of the step of generating neurospheres for MSCs differentiating into functional neurons [8] . However, a few studies advocated that pre-differentiation of MSCs to the desired lineage prior to transplantation may not be necessary, but these cells could be differentiated into neuronal cells after transplantation [33] . Nevertheless, several recent studies showed that MSCs without pre-differentiation did not possess the ability to differentiate into neuronal cells following transplantation [1, 12, 13, 22, 23] .
Bone marrow and adipose tissue are the richest sources of MSCs in dogs, and because of the greater volume of the tissues, they could be easily obtained in relatively large numbers. Previous studies have reported the differentiation of neurospheres derived from both bone marrow and adipose tissue in dogs [9, 14] , and this method may serve a more practical manner to obtain the cells with higher neuronal differentiation properties for cell transplantation. However, the most suitable source of MSCs to generate neurospheres in dogs remains to be clarified. In view of the above, the objective of the present study was to compare the differentiation potential, including the neuronal cell differentiation, of neurospheres derived from cBMMSCs and cADMSCs in order to determine the plasticity of endogenous neural stem cells.
MATERIALS AND METHODS

Animals:
Six male healthy laboratory beagles (1-to 2-year-old; weight, 10-12 kg) were employed in this study to obtain bone marrow or adipose tissue. All animals were anesthetized with propofol before tissue samples were taken. After incubation, anesthesia was maintained with isoflurane (2.0%) in oxygen. At the end of each experiment, the animals were euthanized by additional doses of anesthesia (pentobarbital, 100 mg/kg), followed by intravenous injection of saturated potassium chloride for other experimental purposes. The protocol of this study was approved by the Animal Care Committee of Graduate School of Agriculture and Life Sciences, the University of Tokyo.
Isolation and culture of cBMMSCs: Under general anesthesia, bone marrow was aspirated from the proximal humerus by using a sterilized 15-gauge bone marrow biopsy needle (Angiotech Pharmaceuticals, Inc., Vancouver, Canada) connected to a 10-ml sterilized syringe. Two milliliters of the bone marrow sample was aspirated into the syringe containing 5 ml of heparinized (1,000 units/ml) Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, Carlsbad, CA, U.S.A.).
Stromal cells were isolated immediately after harvesting the bone marrow samples. cBMMSCs were isolated and cultured according to a previous method with minor modifications [10] . Briefly, the bone marrow collected was dissociated, and then resuspended with a pipette. The suspension was layered over Ficoll-Paque solution (GE Healthcare, Little Chalfont, UK) and centrifuged at 400 × g for 30 min. The cells from the topmost layer and within the interface were collected, washed with complete medium consisting of DMEM supplemented with 10% fetal bovine serum (FBS; Nichirei biosciences Inc., Tokyo, Japan) and antibiotics (100 U/ml of Penicillin G, 100 µg/ml of Streptomycin sulfate and 0.25 µg/ml of Amphotericin B) and centrifuged at 210 × g for 5 min. Following centrifugation, the sediments were collected, suspended in hemolysis buffer at room temperature for 5 min and washed with complete medium. The cell suspension was filtered through a 70-µm-pore-size nylon mesh and centrifuged again. Isolated mononuclear cells were resuspended into 5 ml of the cryoprotection medium (CELLBANKER ® 1; Zenoaq, Fukushima, Japan). Finally, the cell suspensions were divided into 5 aliquots and stored in liquid nitrogen for future analysis.
The stored mononuclear cells were used within 12 months and employed for this study. After washing with complete culture medium, an aliquot of the cell suspension was plated in 90-mm petri dishes containing 10 ml of the complete medium and incubated at 37°C in a humidified atmosphere containing 5% carbon dioxide for 48 hr. Subsequently, the nonadherent cells were removed by washing the petri dishes with phosphate-buffered saline (PBS), and the adherent cells were used as cBMMSCs. The culture medium was changed twice a week.
cBMMSCs were passaged until they reached 70-80% confluency. The adherent cells were detached from the 90-mm culture plates with 0.5% trypsin and 1 mM EDTA (Wako, Osaka, Japan) solution. Subsequently, the cells were counted and replated at a density of 8 × 10 3 cells/cm 2 .
Isolation and culture of cADMSCs: Five to ten grams of adipose tissue was collected from the caudal scapular subcutaneous region. Isolation and culture procedures were performed according to a previous method with minor modifications [29] . Briefly, the collected tissue was finely minced and digested with 10 ml of DMEM containing 2 mg/ ml collagenase type I (Wako) at 37°C in a warm water-bath shaker for 2 hr. Another aliquot of complete medium was added to stop the digestion. Following centrifugation at 300 × g for 5 min, the sediments were suspended in hemolysis buffer and incubated at room temperature for 5 min. Subsequently, the sediments were centrifuged and resuspended in complete medium. The cell suspension was filtered through a 70-µm-pore-size nylon mesh and re-centrifuged. Isolated mononuclear cells were counted, and aliquots of 0.5-1.0 × 10 6 cells were re-suspended in 1 ml of cryoprotection medium and stored in liquid nitrogen for future analysis.
The stored adipose-derived mononuclear cells were cultured and passaged by methods similar to those used for cBMMSCs.
Generation of neurospheres and their subsequent differentiation into neuronal cells:
The first-passage cBMMSCs and cADMSCs, which retained in culture until 80% confluency, were utilized for generating neurospheres and subsequently differentiating into neuronal cells. The procedure was performed according to a previous method with minor modifications [9] . Briefly, in total, 6.5 × 10 5 cells were seeded in 60-mm poly-HEMA-coated petri dishes (anti-adhesive substrate; Sigma-Aldrich, St. Louis, MO, U.S.A.) containing neurosphere-generating medium consisting of DMEM/ F12 (Invitrogen Corp.) supplemented with antibiotics, N2 supplement (Invitrogen Corp.), basic fibroblast growth factor (bFGF, 10 ng/ml) and epidermal growth factor (EGF, 20 ng/ml). Neurospheres were collected after 3 days of culture.
The neurospheres were then trypsinized and mechanically dissociated using a fire-polished Pasteur pipette. Cells harvested from neurospheres were counted with a hematocytometer. Subsequently, the harvest ratio was calculated by dividing the number of harvested cells by pre-seeded cells. After washing with DMEM/F12 medium, the cell pellet was resuspended in neural differentiation medium consisting of DMEM/F12 supplemented with N2 supplement, nerve growth factor (100 ng/ml), brain-derived neurotrophic factor (10 ng/ml) and antibiotics. After counting the cells obtained, in total, 2 × 10 4 cells were plated onto PDL/laminin-coated glass coverslips (BD Biosciences, Franklin Lakes, NJ, U.S.A.) for 24 hr.
Quantitative Real-Time Reverse Transcription (RT) PCR: Total RNA was isolated from cBMMSCs, cADMSCs, and the neurospheres that were generated, by using the RNeasy mini kit (QIAGEN, Hilden, Germany) and DNase I (QIAGEN), according to the manufacturer's instructions. Subsequently, 1 µg of total RNA was reverse transcribed using reverse transcriptase (Superscript III, Invitrogen). The cDNA generated by reverse transcription of mRNA was subjected to RT-PCR. The sequences of the primer pairs for the neural stem cell marker Nestin; neural precursor markers, βIII-tubulin and NCAM; glial cell marker, GFAP; stem cells markers, NANOG, OCT4 and SOX2; and the internal control GAPDH are listed in Table 1 .
RT-PCR was performed using KAPA Taq kit (Kapa Biosystems, Woburn, MA, U.S.A.). The PCR conditions were as follows: initial denaturation cycle at 94°C for 2 min, followed by 25-45 cycles consisting of denaturation at 94°C for 20 sec, annealing at 55°C for 15 sec, extension at 68-72°C for 1 min and final extension at 72°C for 1 min. Amplified DNA fragments were electrophoresed on 2% agarose gel and stained with ethidium bromide.
The quantification of mRNA expression levels was carried out on a StepOnePlus TM system (Applied Biosystems, Foster City, CA, U.S.A.). Thundertbird™ SYBR® qPCR mix kit (Toyobo, Osaka, Japan) was used for real-time monitoring of amplification (initial denaturation cycle at 95°C for 1 min, followed by 40 cycles: 95°C for 15 sec, 60°C for 45 sec) with appropriate primers (Table 1) . Nestin, OCT4 and SOX2 were analyzed, and dissociation curve analysis was also performed. The relative mRNA levels were normalized to GAPDH.
Immunofluorescence analysis: The neurospheres and the differentiated neuronal cells were fixed with 4% paraformaldehyde in PBS at room temperature for 15 min and then washed thrice in PBS at 5-min intervals. The supernatant was discarded, and subsequently, the neurospheres were suspended in sucrose (20% w/v in PBS) for 1 day until the neurospheres precipitated to the bottom. The precipitated neurospheres were embedded in OCT compound (Tissue Tek ® , Sakura, Alphen aan den Rijn, Netherlands) and frozen at −80°C. Cryostat sections (10-µm-thick) were processed for immunofluorescence analysis.
Fixed sections were permeabilized and blocked in 0.3% Triton X-100/5% goat serum/PBS and 1% bovine serum albumin for 45 min. Subsequently, the sections were incubated with the following primary antibodies: anti-Nestin Neurosphere sections were incubated only with the primary antibody, anti-Nestin (1:200, MAB5326; Chemicon). Subsequently, the slides were washed thrice with PBS for 5 min, and then incubated with secondary antibodies, FITC-goat anti-rabbit and Cy3-goat anti-mouse IgG (1:200), for 1 hr at room temperature. After 3 washes in PBS for 5 min, the slides were mounted with DAPI and observed by fluorescence microscopy. The proportion of immunolabeled cells was determined by counting at least 500 cells per field in a total of 5 fields with a 20× objective lens and a fluorescent filter.
Statistical analyses: Data were analyzed using the statistical software SPSS ® Statistics 20 (IBM, Somers, NY, GFAP [32] Forward: 5′-CGAGTTACCAGGAGGCACTA-3′ 35 Reverse: 3′-TCCACGGTCTTTACCACAAT-5′ NCAM [32] Forward: 5′-AGGCAGAGCATAGTGAATGC-3′ 35 Reverse: 3′-AGGCTTCACAGGTCAGAGTG-5′ NANOG [19] Forward: 5′-GAATAACCCGAATTGGAGCAG-3′ 45 Reverse: 3′-AGCGATTCCTCTTCACAGTTG-5′
OCT4
Forward: 5′-GCAGTGACTATTCGCAACGA-3′ 35 Reverse: 3′-ATTTGAATGCATGGGAGAGC-5′ SOX2 [34] Forward: 5′-AACCCCAAGATGCACAACTC-3′ 35 Reverse: 3′-CGGGGCCGGTATTTATAATC-5′
GAPDH
Forward: 5′-TGACACCCACTCTTCCACCTTC-3′ 25 Reverse: 3′-CGGTTGCTGTAGCCAAATTCA-5′ U.S.A.). Results were expressed as the mean ± standard deviation. The independent samples (two-tailed) Student ttest was employed for single comparisons. The results of the quantitative real-time PCR were analyzed using the Student t-test with paired two-tailed distribution. The Mann-Whitney U-test was used to compare the small proportions of immunolabeled cells. Statistical significance was set at P<0.05.
RESULTS
Generation of neurospheres:
After 3 days, the cultured cBMMSCs and cADMSCs formed many spherical freefloating cellular aggregates that resembled neurospheres [9] . In addition, a few unaggregated single cells were observed. The diameters of the neurospheres were variable; however, the diameters of the cADMSC-derived neurospheres tended to be larger than those of cBMMSCs. A few neurospheres derived from cADMSCs were approximately 500 µm in diameter, while most of the neurospheres derived from cBMMSCs were approximately ≤100 µm in diameter (Fig.  1A, B) . Immunofluorescence analysis revealed that the neurospheres generated from both cADMSCs and cBMMSCs expressed the neural stem marker Nestin (Fig. 1C, D) .
Following trypsinization, approximately the same number of cells could be harvested from the neurospheres generated from cADMSCs, while only half the number of cells were harvested from the neurospheres generated from cBMMSCs (Fig. 2) .
Gene expression profile of the neurospheres: Real-time PCR analysis showed that the expression of the neural stem cell marker Nestin was upregulated in the neurospheres derived from both cBMMSCs and cADMSCs. Although the expression of the neural precursor markers βIII-tubulin and NCAM was detected in cBMMSCs, cADMSCs and the neurospheres derived from both these cells, the expression of only βIII-tubulin was found to be upregulated in the neurospheres of cADMSCs. Expectedly, the expression of the glial cell marker GFAP was not detected. Notably, the expression of the stem cell markers OCT4 and SOX2 was found to be upregulated in the neurospheres when compared to the expression levels in their precursor MSCs (Figs. 3,  4 ). However, mRNA expression level of the other stem cell marker NANOG was low comparatively in the neurospheres, because it could not be detected when <45 replicate cycles were used in RT-PCR.
Differentiation into neuronal cells: In both cADMSCs and cBMMSCs, about one-third of the cells extended multiple protrusions following neuronal differentiation (data not shown). No apparent difference was observed in the cell numbers that showed morphological changes (Fig. 5) .
The results of the immunofluorescence analysis and the gene expression profiles of the differentiated neuronal cells were similar to those of the neurospheres derived from cADMSCs and cBMMSCs. Expectedly, the expression of Nestin was not detected in the differentiated neuronal cells. While the expression of GFAP and s100 was detected in the neuronal cells, the expression of the glial cell marker MBP was not. Notably, the neuronal markers NF200 and βIII-tubulin were expressed in the differentiated neuronal cells. Interestingly, a significantly higher expression of βIII-tubulin was observed in the neuronal cells derived from cBMMSCs than in those derived from cADMSCs (Fig. 5) .
DISCUSSION
In the present study, we employed growth factors and serum-free medium for the differentiation of MSCs into neurospheres. In contrast, earlier studies that utilized certain chemical agents such as beta-mercaptoethanol (BME), dimethyl sulfoxide (DMSO), and butylated hydroxyanisole (BHA) [36] reported that MSCs could differentiate into cells of neuronal morphology within a few hours, and therefore, these cells may be feasible for transplantation. However, the reversible morphological nature of the differentiated neuronal cells [41] and the toxicity of the chemical substances employed limit their use in clinical trials [39] . On the contrary, cells differentiated in the presence of growth factors and serum-free medium are safer for clinical use.
In this study, adherent stromal cells isolated from the bone marrow and adipose tissue were used as cBMMSCs and cADMSCs [10, 29] . A previous study by Zuk et al. demonstrated that plastic-adherent cells isolated from human adipose tissue, labeled as MSCs, also contained non-MSC population [40] . Another study by Kamishina et al. showed that primary culture comprised different types of adherent cells [11] . Although we did not evaluate the actual percentage of MSCs in the 2 different cultures, the adherent cells were found to be multipotent and expressed MSC-specific surface antigens [11, 19] .
Further, consistent with the gene expression profile of human MSCs, in the present study, the expression of the neural stem cell marker Nestin as well as the neural precursor markers βIII-tubulin and NCAM was detected in cBMMSCs and cADMSCs [3, 31] . Nestin is commonly used as a marker protein for CNS stem/progenitor cells and is expressed in prenatal and postnatal developing brain [6, 38] . βIII-Tubulin is widely regarded as a neuronal marker in immature cells, while NCAM is expressed on most neuroectodermal-derived cell lines and tissues. Therefore, the co-expression of ectoderm markers prior to any external stimulation might indicate the potential of canine MSCs in differentiating toward neuronal lineage.
Furthermore, in this study, the neuronal cells were examined immediately after the first day of differentiation from MSC-derived neurospheres, in contrast to the earlier studies that evaluated them after 6 days. This is because in our preliminary experiments, we found that the differentiated cells with neuron-like morphology detached from the coverslips after the first day of differentiation, and then, they gradually disappeared by the sixth day. Considering this, in contrast to the results of a previous study, the results of our study demonstrated that the original morphology of MSCs could not be maintained [9] . This difference could be attributed to the duration as well as the time point of observation of the neurospheres, although the exact reason is unknown. Spherical cellular aggregates or neurospheres were ob- tained after culturing both cBMMSCs and cADMSCs in the presence of neurosphere-generating medium. We did not observe the acquisition of self-renewal or neurosphereforming properties, as there was no significant increase in cell proliferation. However, the expression of Nestin was found to be upregulated in the neurospheres generated, and immunofluorescence analysis further indicated that they were differentiating toward neural lineage. The transcription factors NANOG, OCT4 and SOX2 play pivotal roles in early embryonic development and are required for the propagation of undifferentiated embryonic stem (ES) cells in culture [2] . The stem cell marker NANOG is essential for primordial germ cells to mature [4] . OCT4 and SOX2 are essential for iPS cell differentiation [30] . SOX2 plays a critical role in the maintenance of embryonic and neural stem cells and neural differentiation of MSCs in vitro [25] . Overexpression of OCT4 is essential for generating functional neurons from adult neural stem cells [7] . In this study, the upregulation of NANOG, OCT4 and SOX2 in the neurospheres derived from both cBMMSCs and cADMSCs indicated that these cells might have a high potential for differentiating toward functional neurons.
For treating spinal cord injury by stem cells in dogs, 1 to 6 millions of cells are commonly transplanted in spinal cord [15, 20, 28] . According to the protocol used in this study, it is possible to obtain more than 10 millions first passage cBMMSCs and cADMSCs through single harvest procedure from one dog. Hence, enough cells from generated neurospheres can be obtained for clinical use. In addition, larger number of cells could be harvested from cADMSCs-derived neurospheres. Therefore, the neurospheres generated from cADMSCs have a considerable advantage over those derived from cBMMSCs, and therefore, they could be utilized for cell transplantation wherein large numbers of cells are required.
Furthermore, immunofluorescence analysis revealed that the neurospheres had the ability to differentiate into neurons and glia. In addition, the expression of the mature neuronal marker MAP2 and the lack of expression of Nestin indicated that the neurospheres had been differentiated into more mature neuronal cells. However, the differences in the levels of expression of the immature neuronal marker βIII-tubulin in the derived neuron-like cells may suggest the different mechanisms of differentiation in cBMMSCs and cADMSCs.
In conclusion, both cBMMSCs and cADMSCs could be differentiated into neurospheres and neuron-like cells and are suitable candidates for cell transplantation. Further, larger number of cells could be harvested from cADMSCderived neurospheres, and therefore, cADMSCs are feasible for cell transplantation wherein large numbers of cells are required. In contrast, by using cBMMSCs, cells expressing the immature neuronal marker βIII-tubulin during neuronal differentiation could be obtained. Future studies employing in vivo cell transplantation models to investigate the effectiveness of BMMSCs and ADMSCs for treating SCI are warranted.
